Profile: Eli Lilly and Co discovers, develops, manufactures & supplies primarily pharmaceutical products. Our Alimta® is a chemotherapy regimen approved by the FDA to treat patients with malignant pleural mesothelioma, who are not candidates for surgery. Our Forteo® is a medicine for osteoporosis patients and it stimulates new bone formation. Our Xigris® is a treatment approved for adult severe-sepsis patients at a high risk of death. Our Evista is indicated for the treatment of osteoporosis and for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. Our Cialis® (tadalafil) is indicated for the treatment of erectile dysfunction.

FDA Registration Number: 1819470

51 to 52 of 52 Products/Services (Click for related suppliers)  Page: 1 [2]

• Ultrasensitive Mouse Insulin kit

• Urinary Glucose Non Quantitative Test System (FDA Code: JIM / 862.1340) A urinary glucose (nonquantitative) test system is a device intended to measure glucosuria (glucose in urine). Urinary glucose (nonquantitative) measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, hypoglycemia, and hyperglycemia.